The $4.5 Billion Mandate That Rewrote Global Health — And Why the Investment Community Hasn't Noticed
USAID was dissolved. The money didn't leave. It was restructured into 26 bilateral government agreements requiring sovereign AI health infrastructure — with American technology explicitly preferred, no incumbent in the market, and $4.5 billion in program funding on the table.
On September 18, 2025, the United States government dissolved USAID.
Most people who read that sentence think it means the U.S. pulled back from global health. It doesn't. What it means — and what has been almost entirely missed by the investment community, the startup ecosystem, and even most health policy observers — is that the U.S. didn't leave global health. It restructured the entire model from the ground up.
The result is the America First Global Health Strategy (AFGHP). And embedded within it is a $4.5 billion mandate for sovereign digital health infrastructure across 26 nations, with American technology companies explicitly preferred as vendors, and no incumbent in the space.
That is an open market. And almost no one has walked through the door.
"USAID didn't get closed. The overhead model that sat on top of it got closed. The money didn't leave. It moved — directly into bilateral government agreements that require American technology to make them work."
What AFGHP Actually Created
The America First Global Health Strategy restructured how the United States engages with partner nations on health by moving from a multilateral, implementing-partner model to a bilateral government-to-government (G2G) framework. The State Department's Bureau of Global Health Security and Diplomacy (BGSD) replaced USAID as the primary vehicle for these agreements.
Twenty-six nations have already signed bilateral Memoranda of Understanding. Those agreements collectively represent more than $20 billion in five-year U.S. health commitments — and each one carries six legally enforceable digital infrastructure requirements:
AI-powered disease surveillance
Real-time community health worker EMR
Maternal and child health data systems
WHO 7-1-7 outbreak response capability
In-country data sovereignty and residency
DHIS2 national system interoperability
These are not aspirational guidelines. They are treaty performance requirements. Nations that cannot demonstrate compliance risk triggering co-investment review clauses. And the State Department — which inherited USAID's responsibilities but not its institutional infrastructure — has no existing vendor relationships for any of these six categories.
$4.5BProgram Funding
Available under DFOP0017890, the primary AFGHP solicitation vehicle
26Signed MOU Nations
Bilateral agreements with enforceable digital infrastructure requirements
FY26The Transition Year
Last year the U.S. covers 100% of health commodity costs — co-investment begins now
The Transition That Changes Everything
FY2026 is the last year the United States covers 100% of health commodity costs for MOU partner nations. Starting in FY2027, countries are expected to progressively co-invest in their own health systems — and the MOU framework requires auditable data infrastructure to verify that co-investment is real, compliant, and traceable.
That creates a structural demand pull that did not exist under USAID. Previously, implementing partners managed program delivery and reported outcomes on annual cycles. Under the AFGHP framework, the co-investment obligation is ongoing — monthly, quarterly, annually — and it must be verifiable by the State Department in near-real time.
Paper registers and spreadsheet reports do not satisfy that requirement. Only sovereign digital infrastructure does. And sovereign digital infrastructure — deployed to a Ministry of Health, owned by the host government, compliant with DHIS2 and FHIR standards, and integrated with U.S. epidemiological reporting systems — is exactly what the six MOU pillars are designed to require.
Why American Technology Is Explicitly Preferred
The AFGHP framework didn't emerge from a vacuum. It was drafted, in significant part, as a response to Chinese infrastructure penetration in developing nations.
Over the past decade, Chinese technology companies — often backed by state capital — have been aggressively building health data infrastructure in the same nations that now hold AFGHP bilateral MOUs. The ICTS Executive Order, issued under the prior administration and maintained under the current one, prohibits Chinese ownership or supply-chain dependency in any vendor adjacent to State Department contracts.
That prohibition, combined with the AFGHP's explicit preference for American commercial technology, creates something unusual: a U.S. foreign policy apparatus that is actively making the commercial case for American tech companies to enter these markets. Not just permitting it. Actively preferring it. By treaty.
What the Solicitation Actually Says
DFOP0017890 — the primary AFGHP funding vehicle, as amended April 14, 2026 — specifies American technology platforms as the preferred implementation architecture for all six MOU digital infrastructure pillars. The solicitation is live on Grants.gov. The Rapid Outbreak Response Addendum adds $290 million specifically for technology-driven outbreak response capability, with an SOI deadline of May 31, 2026.
This is not a future opportunity. It is a current, active, funded procurement.
The Legacy Implementers Cannot Fill This Gap
The organizations that dominated U.S. global health for two decades — Palladium, Chemonics, DT Global, AECOM — built and operated health programs. Their product was program management. Their revenue was overhead on grant dollars.
The AFGHP explicitly identified that overhead model as the structural problem it was designed to fix. The new architecture requires technology platforms that build sovereign infrastructure, transfer ownership to host governments, and license the platform on a recurring basis. That is a fundamentally different revenue model — and a fundamentally different capability set.
Most of the legacy implementing partners do not have the technical architecture, the patent portfolio, or the sovereign data capability to satisfy the six MOU pillars. Some have made acquisitions. None have the integrated full-stack platform that the technical annexes actually require.
The Window Is Open. For Now.
In any sovereign infrastructure market, first-mover advantage is structural. Once a platform is embedded as a Ministry of Health's national data system of record — with clinical workflows, outbreak surveillance, co-investment compliance, and WHO 7-1-7 obligations all routing through one architecture — the switching cost is not vendor switching cost. It is sovereign switching cost.
A competitor cannot underbid their way into an active Ministry deployment without disrupting the nation's treaty compliance obligations to the United States. That is a moat built into the bilateral agreement between two governments.
The solicitations are active. The MOUs are signed. The State Department is searching for commercial partners. The first companies to satisfy the technical requirements will hold the relationships that define this market for the next decade.
The mandate was written. The funding was allocated. American technology was named as the required solution.
The only thing missing is the American technology sector showing up.
Ann Stadjuhar
Chief Strategy Officer · Global Outcomes, Inc.
Ann Stadjuhar leads strategy at Global Outcomes, Inc., the only U.S.-incorporated, SAM.gov-registered sovereign population health intelligence company purpose-built for the America First Global Health Strategy. She writes on the intersection of U.S. health policy, sovereign AI infrastructure, and the investment opportunity that the capital markets have yet to recognize. Follow her on LinkedIn for the full AFGHP investment series.